DE68920063D1 - Derivate von Benzoesäure und Verfahren zu deren Herstellung. - Google Patents

Derivate von Benzoesäure und Verfahren zu deren Herstellung.

Info

Publication number
DE68920063D1
DE68920063D1 DE68920063T DE68920063T DE68920063D1 DE 68920063 D1 DE68920063 D1 DE 68920063D1 DE 68920063 T DE68920063 T DE 68920063T DE 68920063 T DE68920063 T DE 68920063T DE 68920063 D1 DE68920063 D1 DE 68920063D1
Authority
DE
Germany
Prior art keywords
derivatives
preparation
benzoic acid
benzoic
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE68920063T
Other languages
English (en)
Other versions
DE68920063T2 (de
Inventor
Koichi Prof Dr Shudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taiho Pharmaceutical Co Ltd
Original Assignee
SHUDO KOICHI PROF DR CHEM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHUDO KOICHI PROF DR CHEM filed Critical SHUDO KOICHI PROF DR CHEM
Application granted granted Critical
Publication of DE68920063D1 publication Critical patent/DE68920063D1/de
Publication of DE68920063T2 publication Critical patent/DE68920063T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/30—Germanium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68920063T 1988-03-29 1989-03-24 Derivate von Benzoesäure und Verfahren zu deren Herstellung. Expired - Lifetime DE68920063T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63075237A JP2752630B2 (ja) 1988-03-29 1988-03-29 新規安息香酸誘導体及びその製造方法

Publications (2)

Publication Number Publication Date
DE68920063D1 true DE68920063D1 (de) 1995-02-02
DE68920063T2 DE68920063T2 (de) 1995-05-11

Family

ID=13570410

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68920063T Expired - Lifetime DE68920063T2 (de) 1988-03-29 1989-03-24 Derivate von Benzoesäure und Verfahren zu deren Herstellung.

Country Status (4)

Country Link
US (2) US5081271A (de)
EP (1) EP0337176B1 (de)
JP (1) JP2752630B2 (de)
DE (1) DE68920063T2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2761023B2 (ja) * 1989-03-20 1998-06-04 大鵬薬品工業株式会社 新規安息香酸誘導体及びその製造方法
ATE223713T1 (de) * 1995-04-10 2002-09-15 Taiho Pharmaceutical Co Ltd Inhibitor der krebsmetastasierung
AU723930B2 (en) 1996-03-18 2000-09-07 Eisai R&D Management Co., Ltd. Fused-ring carboxylic acid derivatives
EP1025857A4 (de) 1997-10-22 2003-11-12 Eisai Co Ltd Rentinsäure agonisten als prevention und therapeutisches agenz gegen nephritis
ES2204300B1 (es) 2002-07-18 2005-05-01 J. URIACH & CIA S.A. Nuevos derivados del acido 2,4-dihidroxibenzoico.
CN100548288C (zh) * 2004-03-10 2009-10-14 财团法人乙卯研究所 记忆固定促进剂
US20050202055A1 (en) 2004-03-11 2005-09-15 Koichi Shudo, Tokyo, Japan Anti-wrinkle agent
TW200922554A (en) * 2007-10-11 2009-06-01 Taiho Pharmaceutical Co Ltd Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof
TW201012467A (en) * 2008-09-16 2010-04-01 Taiho Pharmaceutical Co Ltd Antitumor agent containing 4-[[3,5-bis(trimethylsilyl)benzoyl]amino]benzoic acid
PL3277272T3 (pl) 2015-03-31 2022-01-24 Syros Pharmaceuticals, Inc. Sposoby stratyfikacji pacjentów do leczenia agonistami receptora kwasu retinowego
US9868994B2 (en) 2016-04-08 2018-01-16 Syros Pharmaceuticals, Inc. Methods of stratifying patients for treatment with retinoic acid receptor-α agonists
KR102457851B1 (ko) 2016-04-08 2022-10-25 사이로스 파마수티컬스, 인크. Aml 및 mds 치료용 rara 효능제

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL25441A (en) * 1966-03-23 1972-01-27 Zilkha A Trialkylsilyl benzamide derivatives
US4271084A (en) * 1978-03-01 1981-06-02 Ryuichi Sato Germanium-containing organic polymer and the process for the production of the same
EP0025965A3 (de) * 1979-09-19 1981-08-12 Yoshitomi Pharmaceutical Industries, Ltd. Organogermaniumverbindungen, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
NL8102268A (nl) * 1980-05-30 1981-12-16 Tno Germaniumverbindingen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een derglijke germaniumverbinding voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel.
JPS601317B2 (ja) * 1982-08-23 1985-01-14 紀博 柿本 親水性及び親油性を併せ有する有機ゲルマニウム化合物
FR2548187B1 (fr) * 1983-07-01 1988-07-15 Asai Germanium Res Inst Composes d'organo-germanium et leurs utilisations therapeutiques en tant qu'inhibiteurs des enzymes qui degradent les peptides opioides
EP0170105B1 (de) * 1984-07-07 1990-10-17 Koichi Prof. Dr. Shudo Benzoesäurederivate
JPS61145115A (ja) * 1984-12-18 1986-07-02 Asai Gerumaniumu Kenkyusho:Kk 塵肺症患者用風邪症候群予防剤
JPH0662407B2 (ja) * 1984-12-25 1994-08-17 株式会社三和化学研究所 安定化された３―オキシゲルミルプロピオン酸ポリマーを有効成分とする免疫調整剤
US4772628A (en) * 1985-12-28 1988-09-20 Asai Germanium Research Institute Organogermanium compound and antitumor agent composed mainly of this compound
US4798187A (en) * 1986-11-07 1989-01-17 Sharon Manufacturing Company Low profile fuel injection rail
US4808631A (en) * 1986-11-07 1989-02-28 Hoffmann-La Roche Inc. Aromatic acid derivatives

Also Published As

Publication number Publication date
DE68920063T2 (de) 1995-05-11
EP0337176A2 (de) 1989-10-18
EP0337176A3 (en) 1990-11-28
US5155249A (en) 1992-10-13
JP2752630B2 (ja) 1998-05-18
US5081271A (en) 1992-01-14
JPH01249783A (ja) 1989-10-05
EP0337176B1 (de) 1994-12-21

Similar Documents

Publication Publication Date Title
DE58909834D1 (de) Phthalimidoperoxihexansäure, Verfahren zu deren Herstellung und deren Verwendung
DE3786781T2 (de) 3-Pyrrolidinylthio-1-azabicyclo[3.2.0]hept-2-en-2-carbonsäure-Derivate und Verfahren zu deren Herstellung.
DE3650018T2 (de) Chinolin-Derivate und Verfahren zu deren Herstellung.
DE3751537D1 (de) Polypeptid- und Proteinderivate und Verfahren zu deren Herstellung.
DE69029186T2 (de) 3-Indolbrenztraubensäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung
DE3581328D1 (de) Derivate des menschlichen alpha-1-antitrypins und verfahren zu deren herstellung.
ATE29383T1 (de) Arzneimittelzubereitungen von oxicam-derivaten und verfahren zu deren herstellung.
DE69029868D1 (de) Lösung von hochmolekularen Polycarbodiimiden sowie Verfahren zu deren Herstellung
DE3853608T2 (de) Zyklische Anthranil-carbonsäurederivate und Verfahren zu deren Herstellung.
DE19775081I2 (de) Benzimidazolderivate Verfahren zu deren Herstellung und deren therapeutische Anwendung
DE68920063T2 (de) Derivate von Benzoesäure und Verfahren zu deren Herstellung.
DE68900485D1 (de) Derivate von phenoxyalkylcarbonsauere und verfahren zu ihrer herstellung.
PT83239A (de) Aminosaeure-derivate verfahren zu ihrer herstellung und verwendung
DE69210059T2 (de) Verfahren zur Herstellung von Aluminophosphatverbindungen und substituierten Derivaten von VFI-Strukturtyp
ATA328587A (de) Neue furanuronsaeure-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen
DE69225625T2 (de) Carbaminsäurederivate und Verfahren zu ihrer Herstellung
DE69118850T2 (de) Derivate der 1,4-Benzothiazin-2-essigsäure, Verfahren zu ihrer Herstellung und ihre Verwendung
PT84565A (de) Substituierte 4-amino-3-hydroxybuttersauere-derivate verfahren zu deren herstellung diese enthaltende mittel und ihre verwendung
DE68923442D1 (de) N-substituierte Acylaminosäure-Verbindungen, Verfahren zu deren Herstellung und deren Verwendung.
DE3751866D1 (de) Polyimidfolie und Verfahren zu deren Herstellung
DE3887283D1 (de) Kondensierte Acetessigsäureester-Titanchelate und Verfahren zu deren Herstellung.
ATE37870T1 (de) Verfahren zur herstellung von acyloxybenolsulfonsaeuren und deren salzen.
DE69420757T2 (de) Verfahren zu Herstellung von Pantothensäure Derivate und Ausgangsmaterialien zu ihrer Herstellung
DE69031409D1 (de) 8-Carboxy-1,2,3,4-tetrahydroquinolin-6-yl-essigsäure und Verfahren zu dessen Herstellung
DE3880904T2 (de) Weinsäureamidderivate und Verfahren zu ihrer Herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: TAIHO PHARMACEUTICAL CO., LTD., TOKIO/TOKYO, JP

8381 Inventor (new situation)

Free format text: SHUDO, KOICHI,PROF. DR.CHEM., TOKIO/TOKYO, JP